SMTL ID : 6mo8.2 (2 other biounits)

N-terminal bromodomain of human BRD2 in complex with 4,4'-(quinoline-5,7-diyl)bis(3,5-dimethylisoxazole) inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: W.29, R.32 3 PLIP interactions: 3 interactions with chain A Water bridges: A:R.32, A:R.32 Salt bridges: A:R.32

1 x JWD: 5,7-bis(3,5-dimethyl-1,2-oxazol-4-yl)quinoline(Non-covalent)

JWD.2: 8 residues within 4Å: Chain A: W.29, P.30, F.31, V.35, L.40, L.42, N.88, I.94 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.29, A:W.29, A:P.30, A:F.31, A:L.40, A:L.42, A:I.94 Hydrogen bonds: A:N.88 Water bridges: A:Q.33, A:C.84

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sperandio, D. et al., Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg. Med. Chem. (2019)

Release Date

2019-01-23

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bromodomain-containing protein 2

Related Entries With Identical Sequence